SEC Form 4 · accession 0001493152-18-012925
Provention Bio, Inc. · PRVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avery W Catlin
Director
Period of report
Sep 5, 2018
Accepted (ET)
Sep 5, 2018 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001695357
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2,F1 | $3.88 | Sep 5, 2018 | A | 128,981 | A | — | Sep 5, 2028 | Common Stock, par value $0.0001 | 128,981 | 128,981 | D |
Explanation of responses
- F1The option vests in eight equal semi-annual installments commencing on March 5, 2019 and will become fully vested on September 5, 2022.
- F2The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.